There are no published data on post-transplant outcomes in durable ventricular assist device (VAD)-supported adult congenital heart disease (ACHD) patients.

Methods

We compared post-transplant outcomes in VAD-supported vs non-VAD-supported ACHD patients using the Scientific Registry of Transplant Recipients.

Results

At 1 year, there was no difference in post-transplant mortality between VAD-supported (12 patients) and non-VAD-supported (671 patients) ACHD patients.

Conclusions

In appropriate ACHD patients, VAD use as a bridge to transplant is a reasonable strategy.

CONFLICT OF INTEREST

The authors declare that they have no conflicts of interest with the contents of this article.

References

1Engelings CC, Helm PC, Abdul-Khaliq H, et al. Cause of death in adults with congenital heart disease—An analysis of the German National Register for Congenital Heart Defects. Int J Cardiol. 2016; 211: 31-36. https://doi.org/10.1016/j.ijcard.2016.02.133.
10.1016/j.ijcard.2016.02.133
PubMed Web of Science® Google Scholar
2Alshawabkeh LI, Hu N, Carter KD, et al. Wait-list outcomes for adults with congenital heart disease listed for heart transplantation in the U.S. J Am Coll Cardiol. 2016; 68(9): 908-917. https://doi.org/10.1016/j.jacc.2016.05.082.
10.1016/j.jacc.2016.05.082
PubMed Web of Science® Google Scholar
3Everitt MD, Donaldson AE, Stehlik J, et al. Would access to device therapies improve transplant outcomes for adults with congenital heart disease? Analysis of the United Network for Organ Sharing (UNOS). J Heart Lung Transplant. 2011; 30(4): 395-401. https://doi.org/10.1016/j.healun.2010.09.008.
10.1016/j.healun.2010.09.008
PubMed Web of Science® Google Scholar
4Cedars A, Vanderpluym C, Koehl D, Cantor R, Kutty S, Kirklin JK. An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of hospitalization, functional status, and mortality after mechanical circulatory support in adults with congenital heart disease. J Hear Lung Transplant. 2018; 37(5): 619-630. https://doi.org/10.1016/j.healun.2017.11.010.
10.1016/j.healun.2017.11.010
PubMed Web of Science® Google Scholar
5Davies RR, Russo MJ, Yang J, Quaegebeur JM, Mosca RS, Chen JM. Listing and transplanting adults with congenital heart disease. Circulation. 2011; 123(7): 759-767. https://doi.org/10.1161/CIRCULATIONAHA.110.960260.
10.1161/CIRCULATIONAHA.110.960260
PubMed Web of Science® Google Scholar
6VanderPluym CJ, Cedars A, Eghtesady P, et al. Outcomes following implantation of mechanical circulatory support in adults with congenital heart disease: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS).J Hear Lung Transplant. 2018; 37(1): 89-99. https://doi.org/10.1016/j.healun.2017.03.005.
10.1016/j.healun.2017.03.005
PubMed Web of Science® Google Scholar
7Maxwell BG, Wong JK, Sheikh AY, Lee P, Lobato RL. Heart transplantation with or without prior mechanical circulatory support in adults with congenital heart disease. Eur J Cardiothorac Surg. 2014; 45(5): 842-846. https://doi.org/10.1093/ejcts/ezt498.
10.1093/ejcts/ezt498
PubMed Web of Science® Google Scholar
8 Scientific Registry of Transplant Recipientshttps://www.srtr.org/. Accessed November 11, 2018.
Google Scholar

Citing Literature

Volume14, Issue6

November/December 2019

Pages 958-962

Impact of durable ventricular assist devices on post-transplant outcomes in adults with congenital heart disease

Abstract

Background

Methods

Results

Conclusions

CONFLICT OF INTEREST

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Impact of durable ventricular assist devices on post-transplant outcomes in adults with congenital heart disease

Abstract

Background

Methods

Results

Conclusions

CONFLICT OF INTEREST

References

Citing Literature

References

Related

Information